These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8354165)

  • 1. Advances in mechanisms of activation and deactivation of environmental chemicals.
    Goldstein JA; Faletto MB
    Environ Health Perspect; 1993 Apr; 100():169-76. PubMed ID: 8354165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease.
    Gonzalez FJ; Gelboin HV
    J Toxicol Environ Health; 1993; 40(2-3):289-308. PubMed ID: 8230303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer.
    Nebert DW; McKinnon RA; Puga A
    DNA Cell Biol; 1996 Apr; 15(4):273-80. PubMed ID: 8639263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phase II drug metabolizing enzymes in cancer chemoprevention.
    Jana S; Mandlekar S
    Curr Drug Metab; 2009 Jul; 10(6):595-616. PubMed ID: 19702535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and Phase II enzyme polymorphisms and childhood cancer.
    Swinney R; Hsu S; Tomlinson G
    J Investig Med; 2006 Sep; 54(6):303-20. PubMed ID: 17134614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytochrome-P450 enzymes metabolize N-(2-methoxyphenyl)hydroxylamine, a metabolite of the carcinogens o-anisidine and o-nitroanisole, thereby dictating its genotoxicity.
    Naiman K; Martínková M; Schmeiser HH; Frei E; Stiborová M
    Mutat Res; 2011 Dec; 726(2):160-8. PubMed ID: 21946300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of PCR techniques in toxicology].
    Kazubek M; Długosz A; Pawlik K
    Postepy Hig Med Dosw (Online); 2010 Oct; 64():482-9. PubMed ID: 20966506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.
    Hayes JD; Pulford DJ
    Crit Rev Biochem Mol Biol; 1995; 30(6):445-600. PubMed ID: 8770536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past and future applications of CYP450-genetic polymorphisms for biomonitoring of environmental toxicants.
    Yi B; Yang JY; Yang M
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(4):353-77. PubMed ID: 18000786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of selected genes of toxication and detoxication pathways in peripheral blood lymphocytes as a biomarker for predicting toxicity of environmental chemicals.
    Sharma A; Saurabh K; Yadav S; Jain SK; Parmar D
    Int J Hyg Environ Health; 2013 Nov; 216(6):645-51. PubMed ID: 23273579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of metabolizing enzymes by bisphenol a in human and animal models.
    Quesnot N; Bucher S; Fromenty B; Robin MA
    Chem Res Toxicol; 2014 Sep; 27(9):1463-73. PubMed ID: 25142872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recruitment of co-metabolic enzymes for environmental detoxification of organohalides.
    Wackett LP
    Environ Health Perspect; 1995 Jun; 103 Suppl 5(Suppl 5):45-8. PubMed ID: 8565909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug metabolic enzymes in developmental toxicology.
    Miller MS; Juchau MR; Guengerich FP; Nebert DW; Raucy JL
    Fundam Appl Toxicol; 1996 Dec; 34(2):165-75. PubMed ID: 8954747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of allyl sulfides on the induction of phase II detoxification enzymes and liver injury by carbon tetrachloride.
    Fukao T; Hosono T; Misawa S; Seki T; Ariga T
    Food Chem Toxicol; 2004 May; 42(5):743-9. PubMed ID: 15046820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diversity of P 450: biology and application of diversozyme].
    Yang M
    J UOEH; 1998 Mar; 20(1):73-7. PubMed ID: 9551530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics.
    Philpot RM; Smith BR
    Environ Health Perspect; 1984 Apr; 55():359-67. PubMed ID: 6376107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid catabolism in marine and freshwater fish.
    James MO
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):167-75. PubMed ID: 20955793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.